Companies
Abbott Laboratories
S&P 500Health Care· USA

ABT

Status-Quo-Player

Abbott Laboratories

$100.69

+0.42%

Open $100.13·Prev $100.27

as of 13 Apr

STATUS-QUO-PLAYER

Power Core

Moat: Abbott's moat is its ability to embed recurring revenue models inside product categories where competitors still sell discrete units.

Published1 Apr 2026
UniverseS&P 500
SectorHealth Care

Direction of Movement

Libre-Led Growth With Device Pipeline Reaching Inflection

ROC 200

-23.2%

Company Profile

Abbott Laboratories is a diversified global healthcare company that discovers, develops, manufactures, and sells a broad portfolio of health care products worldwide. It operates across four key segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices, addressing needs from chronic disease management to acute diagnostics. The company offers generic pharmaceuticals treating conditions such as pancreatic exocrine insufficiency, irritable bowel syndrome, dyslipidemia, hypertension, hypothyroidism, pain, fever, inflammation, and migraine, alongside anti-infectives, influenza vaccines, and gastrointestinal regulators. Notable products include cardiovascular devices like pacemakers and stents, diabetes management tools such as continuous glucose monitors, pediatric and adult nutritional formulas, and advanced diagnostic equipment like immunoassays and point-of-care testing kits. With approximately 114,000 employees and a history dating back to 1888, Abbott Laboratories generates the majority of its sales outside the United States, playing a pivotal role in advancing medical innovation, improving patient outcomes, and supporting global health initiatives through its extensive reach in consumer, institutional, and professional markets.

Sector

Healthcare

Industry

Medical Devices

Employees

115,000

This page is for informational purposes only and does not constitute investment advice. L17X Research is an independent research service.